Moderate to Severe Genital Psoriasis
Immunology
Prevalence
3000.0 / 100K
Incidence
78.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
Frequently asked questions
How many drugs are in development for Moderate to Severe Genital Psoriasis?
BioSniper tracks 1 drug in development for Moderate to Severe Genital Psoriasis across 1 company.
How many clinical trials target Moderate to Severe Genital Psoriasis?
There are 1 clinical trial targeting Moderate to Severe Genital Psoriasis tracked by BioSniper.
What is the prevalence of Moderate to Severe Genital Psoriasis?
The estimated prevalence of Moderate to Severe Genital Psoriasis is approximately 3000.0 per 100,000 population.
Deep-dive into Moderate to Severe Genital Psoriasis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis